Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms
Effect of Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry in Medical Staff During the COVID-19 Pandemic: A Multicentric Randomized Controlled Trial
1 other identifier
interventional
236
1 country
1
Brief Summary
The purpose of this randomized controlled trial is to determine the effect of two behavioral interventions: brief cognitive-behavioral therapy and crisis intervention therapy through telepsychiatry, over the level of perceived stress, anxiety, depression and post-traumatic stress symptoms during the COVID-19 pandemic in medical residents and medical staff at three hospitals in two cities of Honduras.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable anxiety
Started Jun 2020
Shorter than P25 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2020
CompletedFirst Posted
Study publicly available on registry
May 19, 2020
CompletedStudy Start
First participant enrolled
June 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedJuly 2, 2020
June 1, 2020
5 months
May 3, 2020
June 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Rate reduction in Depressive symptoms
Patient Health Questionnaire 9 scale (PHQ-9), a 9 item scale with a score range from 0 to 27. A higher score means a worse outcome.
6 months after psychotherapeutic intervention has started
Rate reduction in Anxiety symptoms
General Anxiety Disorder 7 Scale (GAD-7), a 7 item scale with a score range from 0 to 21. A higher score means a worse outcome.
6 months after psychotherapeutic intervention has started
Rate reduction in Post traumatic Stress symptoms
Post-traumatic Stress Scale for DSM-5 (PCL-5), a 20 item scale with a score range from 0 to 80. A higher score means a worse outcome.
6 months after psychotherapeutic intervention has started
Rate reduction in Perceived stress level
Perceived stress scale (PSS), a 10 item scale with a score range from 0 to 40. A higher score means a worse outcome.
6 months after psychotherapeutic intervention has started
Study Arms (2)
Brief cognitive behavioral therapy
EXPERIMENTALMedical staff (medical doctors and residents) who will receive brief cognitive behavioral therapy through telepsychiatry.
Crisis intervention therapy
ACTIVE COMPARATORMedical staff (medical doctors and residents) who will receive 3 sessions of crisis intervention therapy through telepsychiatry.
Interventions
9 structured psychotherapy sessions, weekly, 60-90 minutes duration. Provided by one therapist and one co-therapist. Provided through telepsychiatry.
3 structured sessions of crisis intervention. One session each week for three weeks. Provided by one therapist and one co-therapist. Provided through telepsychiatry.
Eligibility Criteria
You may qualify if:
- Medical doctors and medical residents 18 years and older, from UNAH medical school and Hospital de Occidente.
- Medical doctors and medical residents whom during the initial screening show positive scores in Patient Health Questionnaire-2 and Generalized Anxiety Disorder scale-2
- Access to internet and an electronic device
You may not qualify if:
- Medical doctors and medical residents referring a history of psychiatric disorders
- Medical residents that belong to the Psychiatry Residency Program
- Medical residents and medical doctors that have been diagnosed with COVID-19
- Medical doctors and residents whom during evaluations show severe symptoms of depression, anxiety and post-traumatic stress symptoms
- Medical doctors and residents with negative screening in Patient Health Questionnaire-2 and Generalized Anxiety Disorder Scale-2
- Participants that do not have access to internet connection or an electronic device.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Nacional Autónoma de Honduras
Tegucigalpa, Francisco Morazán Department, 11101, Honduras
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
José R Galindo-Donaire, MD
Universidad Nacional Autonoma de Honduras
- PRINCIPAL INVESTIGATOR
Elena N Reyes-Flores, MD
Universidad Nacional Autonoma de Honduras
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Investigators will not take part in the baseline symptom evaluation of subjects or the post-intervention evaluation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Resident
Study Record Dates
First Submitted
May 3, 2020
First Posted
May 19, 2020
Study Start
June 30, 2020
Primary Completion
November 30, 2020
Study Completion
December 30, 2020
Last Updated
July 2, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share